Company profile: HemoSonics
1.1 - Company Overview
Company description
- Provider of in vitro diagnostics to characterize hemostasis, featuring the Quantra Hemostasis System using patented sonorheometry (SR). Offerings include the Quantra Analyzer; QPlus and QStat cartridges to assess clot time, stiffness, fibrinogen/platelet contributions and lysis; quality controls; a desktop remote viewer; and connectivity to electronic medical records and point-of-care device data.
Products and services
- QPlus Cartridge: A procedure-specific cartridge for cardiovascular and major orthopedic surgery that measures clot time, clot stiffness, and the respective fibrinogen and platelet contributions
- QStat Cartridge: A multi-parameter cartridge for trauma and liver transplantation that evaluates clot time, clot stiffness, fibrinogen and platelet contributions, plus clot stability to lysis
- Quantra Hemostasis System: An SR-based hemostasis analyzer for surgical and trauma settings integrating the analyzer, QPlus and QStat cartridges, and two-level quality controls, delivering faster, easier operation and lower cost than competing technologies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HemoSonics
Biomaneo
HQ: France
Website
- Description: Provider of medical analysis kits for the detailed analysis of proteins by mass spectrometry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomaneo company profile →
Tasso
HQ: United States
Website
- Description: Provider of medical innovation changing the way diagnostics are delivered.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tasso company profile →
Immucor
HQ: United States
Website
- Description: Provider of transfusion and transplantation diagnostic products, including serology reagents, instruments, and molecular solutions for donor-recipient compatibility and pre-transfusion testing; transplant tools to guide recipient care and monitor rejection; platelet antibody screening and antigen identification; coagulation assays; HLA donor screening; and NGS HLA typing kits and software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immucor company profile →
Quotient
HQ: United States
Website
- Description: Provider of transfusion and blood bank diagnostics solutions, including MosaiQ, a fully automated in‑vitro platform performing multiple tests on a single patient sample to optimize laboratory resources and shorten time to diagnosis; Alba, manual reagents for blood bank diagnostics with technical and customer support; and MosaiQ AiPlex CTD, a microarray immunoassay for connective tissue diseases that detects multiple autoantibodies in one panel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient company profile →
CellaVision
HQ: Sweden
Website
- Description: Provider of digital hematology microscopy solutions, including analyzers, instruments, reagents, and software, that automate and simplify routine analysis of blood and other body fluids and support hematology laboratory differentials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellaVision company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HemoSonics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HemoSonics
2.2 - Growth funds investing in similar companies to HemoSonics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HemoSonics
4.2 - Public trading comparable groups for HemoSonics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →